Monitor for any subsequent filing naming a replacement director or any unusual board activity. A single director resignation for health reasons is routine and does not signal operational issues.
LGVN drugs
LGVN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $1.81entry
- T+1 · 8d ago +11.05%α +8.68% · $2.01
- T+5 · 4d ago +37.57%α +34.97% · $2.49
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Board member Ursula Ungaro resigned immediately from Longeveron's Board and all committees on November 1, 2026, citing personal health issues. The filing states the resignation was not due to any disagreement with the company. No replacement has been named.
Key Facts
- Ursula Ungaro resigned from the Board of Directors effective November 1, 2026
- Resignation also covers Audit, Compensation, Nominating and Corporate Governance, and Special Committees
- Reason given: personal health issues, not a disagreement with the company
- No replacement named in the filing
Financial Impact
No financial impact stated; a single board resignation with no stated disagreement
Risk Factors
- Loss of board diversity or specific expertise if not replaced promptly
- Potential for additional departures if underlying governance issues exist, though none are indicated
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-116360 |
| Document: 0001213900-26-116360-index-headers.html | 0001213900-26-116360 |
| Document: 0001213900-26-116360-index.html | 0001213900-26-116360 |
| Document: 0001213900-26-116360.txt | 0001213900-26-116360 |
Track record
22 reports on LGVN
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +44.65% at T+20 after the Sep 16, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $2.53 Now $2.14 +15.42% settles Feb 12
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $2.49 Now $2.14 −14.06% settles Feb 11
- Nov 12, 20264d ago 8-K Bearish 7/10 No price data
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $2.49 Now $2.14 +14.06% settles Feb 11
- Nov 5, 202611d ago SC 13G/A Bearish 5/10 Entry $1.81 Now $2.14 −18.23% settles Feb 4
- Nov 5, 202611d ago 8-K Neutral 2/10 Viewing Entry $1.81 Now $2.14 +18.23% settles Feb 4
- Oct 26, 202621d ago 8-K Neutral 5/10 Entry $1.73 Now $2.14 +23.70% settles Jan 25
- Oct 26, 202621d ago Press Release Mixed 6/10 Entry $1.61 Now $2.14 +33.33% settles Jan 22
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $1.50 Now $2.14 +42.67% settles Jan 12
- Sep 16, 20268w ago Press Release Bearish 7/10 Entry $2.71 Now $2.14 +21.03% settles Dec 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers